Identification of early disease progression in an ALS rat model
Authors:
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 415 (3) , 264-268
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Colivelin prolongs survival of an ALS model mouseBiochemical and Biophysical Research Communications, 2006
- Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral SclerosisJournal of Neuroscience, 2006
- Disease progression of human SOD1 (G93A) transgenic ALS model ratsJournal of Neuroscience Research, 2005
- Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesisBehavioural Brain Research, 2005
- Optimal methods to characterize the G93A mouse model of ALSAmyotrophic Lateral Sclerosis, 2005
- Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALSNature Neuroscience, 2004
- UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALSAnnual Review of Neuroscience, 2004
- Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in miceHuman Molecular Genetics, 2003
- Current status of SOD1 mutations in familial amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993